Agree wolfi, and as AMS started amiss even on the 1b AML results ( the original cohort of 15), yet reported on the 1b and 2a breastcancer, and the 1b Ovarian cancer readouts. Agree, If reporting practices improve then shareholders could get a more comprehensive understanding of results.
Quarter out soon, maybe someone on the team is taking note.., maybe not.
Agree wolfi, and as AMS started amiss even on the 1b AML results...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $31.40M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 3.9¢ | $72.73K | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 436541 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 560576 | 1 |
View Market Depth
| Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |